study population

A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury

Study Overview The clinical trial investigated the efficacy of MLC901, also known as NeuroAiD II, in addressing cognitive deficits resulting

A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury Read Post »

The efficacy and safety of intrathecal pemetrexed for leptomeningeal metastasis from non-small cell lung cancer: a single-arm meta-analysis of Chinese patients

Study Overview This study focuses on evaluating the effectiveness and safety of intrathecal pemetrexed in addressing leptomeningeal metastasis specifically in

The efficacy and safety of intrathecal pemetrexed for leptomeningeal metastasis from non-small cell lung cancer: a single-arm meta-analysis of Chinese patients Read Post »

Impact of anticoagulant therapy on delayed intracranial haemorrhage after traumatic brain injury: A study on the role of repeat CT scans and extended observation

Study Overview This study investigates the implications of anticoagulant therapy on the risk of delayed intracranial hemorrhage following traumatic brain

Impact of anticoagulant therapy on delayed intracranial haemorrhage after traumatic brain injury: A study on the role of repeat CT scans and extended observation Read Post »

Scroll to Top